nodes	percent_of_prediction	percent_of_DWPC	metapath
Milrinone—Arrhythmia supraventricular—Ixabepilone—breast cancer	0.0314	0.0454	CcSEcCtD
Milrinone—Infusion site reaction—Paclitaxel—breast cancer	0.0292	0.0422	CcSEcCtD
Milrinone—Infusion site reaction—Docetaxel—breast cancer	0.0247	0.0358	CcSEcCtD
Milrinone—Amrinone—TNF—breast cancer	0.0207	1	CrCbGaD
Milrinone—Arrhythmia supraventricular—Gemcitabine—breast cancer	0.0139	0.0201	CcSEcCtD
Milrinone—Liver function test abnormal—Toremifene—breast cancer	0.00982	0.0142	CcSEcCtD
Milrinone—Arrhythmia supraventricular—Capecitabine—breast cancer	0.00955	0.0138	CcSEcCtD
Milrinone—Angina pectoris—Toremifene—breast cancer	0.00895	0.013	CcSEcCtD
Milrinone—Anaphylactic shock—Fluoxymesterone—breast cancer	0.00811	0.0117	CcSEcCtD
Milrinone—Hypokalaemia—Ixabepilone—breast cancer	0.00804	0.0116	CcSEcCtD
Milrinone—Angina pectoris—Exemestane—breast cancer	0.00788	0.0114	CcSEcCtD
Milrinone—Liver function test abnormal—Anastrozole—breast cancer	0.00768	0.0111	CcSEcCtD
Milrinone—Angina pectoris—Ixabepilone—breast cancer	0.00743	0.0108	CcSEcCtD
Milrinone—Angina pectoris—Anastrozole—breast cancer	0.007	0.0101	CcSEcCtD
Milrinone—Angina pectoris—Letrozole—breast cancer	0.007	0.0101	CcSEcCtD
Milrinone—Arrhythmia—Toremifene—breast cancer	0.00657	0.00951	CcSEcCtD
Milrinone—Tremor—Toremifene—breast cancer	0.006	0.00868	CcSEcCtD
Milrinone—Anaphylactic shock—Lapatinib—breast cancer	0.00576	0.00833	CcSEcCtD
Milrinone—Chest pain—Fulvestrant—breast cancer	0.00552	0.00799	CcSEcCtD
Milrinone—Chest pain—Toremifene—breast cancer	0.00545	0.00789	CcSEcCtD
Milrinone—Torsade de pointes—Capecitabine—breast cancer	0.00528	0.00764	CcSEcCtD
Milrinone—Liver function test abnormal—Tamoxifen—breast cancer	0.00525	0.0076	CcSEcCtD
Milrinone—Liver function test abnormal—Melphalan—breast cancer	0.00514	0.00744	CcSEcCtD
Milrinone—Thrombocytopenia—Toremifene—breast cancer	0.00512	0.0074	CcSEcCtD
Milrinone—Headache—Fluoxymesterone—breast cancer	0.00508	0.00735	CcSEcCtD
Milrinone—Ventricular extrasystoles—Paclitaxel—breast cancer	0.00499	0.00723	CcSEcCtD
Milrinone—Angina pectoris—Vinblastine—breast cancer	0.00493	0.00714	CcSEcCtD
Milrinone—Arrhythmia—Idarubicin—breast cancer	0.00488	0.00706	CcSEcCtD
Milrinone—Ventricular fibrillation—Capecitabine—breast cancer	0.00483	0.00699	CcSEcCtD
Milrinone—Chest pain—Exemestane—breast cancer	0.0048	0.00694	CcSEcCtD
Milrinone—Angina pectoris—Tamoxifen—breast cancer	0.00479	0.00693	CcSEcCtD
Milrinone—Bronchospasm—Melphalan—breast cancer	0.00474	0.00685	CcSEcCtD
Milrinone—Angina pectoris—Goserelin—breast cancer	0.00458	0.00662	CcSEcCtD
Milrinone—Chest pain—Ixabepilone—breast cancer	0.00453	0.00655	CcSEcCtD
Milrinone—Ventricular tachycardia—Paclitaxel—breast cancer	0.00451	0.00653	CcSEcCtD
Milrinone—Thrombocytopenia—Exemestane—breast cancer	0.0045	0.00652	CcSEcCtD
Milrinone—Chest pain—Letrozole—breast cancer	0.00426	0.00617	CcSEcCtD
Milrinone—Chest pain—Anastrozole—breast cancer	0.00426	0.00617	CcSEcCtD
Milrinone—Thrombocytopenia—Ixabepilone—breast cancer	0.00425	0.00615	CcSEcCtD
Milrinone—Bronchospasm—Vinorelbine—breast cancer	0.00414	0.00599	CcSEcCtD
Milrinone—Angina pectoris—Vinorelbine—breast cancer	0.0041	0.00593	CcSEcCtD
Milrinone—Ventricular extrasystoles—Capecitabine—breast cancer	0.0041	0.00593	CcSEcCtD
Milrinone—Anaphylactic shock—Anastrozole—breast cancer	0.00409	0.00591	CcSEcCtD
Milrinone—Anaphylactic shock—Letrozole—breast cancer	0.00409	0.00591	CcSEcCtD
Milrinone—Hypotension—Ixabepilone—breast cancer	0.00406	0.00587	CcSEcCtD
Milrinone—Chest pain—Idarubicin—breast cancer	0.00405	0.00585	CcSEcCtD
Milrinone—Chest pain—Raloxifene—breast cancer	0.00405	0.00585	CcSEcCtD
Milrinone—Anaphylactic shock—Idarubicin—breast cancer	0.00388	0.00561	CcSEcCtD
Milrinone—Thrombocytopenia—Idarubicin—breast cancer	0.0038	0.0055	CcSEcCtD
Milrinone—Thrombocytopenia—Raloxifene—breast cancer	0.0038	0.0055	CcSEcCtD
Milrinone—Hypokalaemia—Irinotecan—breast cancer	0.00365	0.00529	CcSEcCtD
Milrinone—Hypokalaemia—Mitoxantrone—breast cancer	0.00365	0.00529	CcSEcCtD
Milrinone—Rash—Lapatinib—breast cancer	0.00363	0.00525	CcSEcCtD
Milrinone—Dermatitis—Lapatinib—breast cancer	0.00363	0.00525	CcSEcCtD
Milrinone—Liver function test abnormal—Gemcitabine—breast cancer	0.00361	0.00522	CcSEcCtD
Milrinone—Headache—Lapatinib—breast cancer	0.00361	0.00522	CcSEcCtD
Milrinone—Tremor—Chlorambucil—breast cancer	0.00361	0.00522	CcSEcCtD
Milrinone—Hypokalaemia—Gemcitabine—breast cancer	0.00356	0.00515	CcSEcCtD
Milrinone—Arrhythmia—Tamoxifen—breast cancer	0.00352	0.00509	CcSEcCtD
Milrinone—Ventricular arrhythmia—Epirubicin—breast cancer	0.00348	0.00504	CcSEcCtD
Milrinone—Arrhythmia—Melphalan—breast cancer	0.00344	0.00498	CcSEcCtD
Milrinone—Angina pectoris—Irinotecan—breast cancer	0.00338	0.00489	CcSEcCtD
Milrinone—Arrhythmia—Goserelin—breast cancer	0.00336	0.00486	CcSEcCtD
Milrinone—Rash—Fulvestrant—breast cancer	0.00334	0.00483	CcSEcCtD
Milrinone—Dermatitis—Fulvestrant—breast cancer	0.00334	0.00483	CcSEcCtD
Milrinone—Bronchospasm—Gemcitabine—breast cancer	0.00332	0.00481	CcSEcCtD
Milrinone—Headache—Fulvestrant—breast cancer	0.00332	0.0048	CcSEcCtD
Milrinone—Rash—Toremifene—breast cancer	0.0033	0.00477	CcSEcCtD
Milrinone—Dermatitis—Toremifene—breast cancer	0.00329	0.00476	CcSEcCtD
Milrinone—Headache—Toremifene—breast cancer	0.00327	0.00474	CcSEcCtD
Milrinone—Angina pectoris—Fluorouracil—breast cancer	0.00324	0.00468	CcSEcCtD
Milrinone—Ventricular arrhythmia—Doxorubicin—breast cancer	0.00322	0.00466	CcSEcCtD
Milrinone—Thrombocytopenia—Chlorambucil—breast cancer	0.00308	0.00445	CcSEcCtD
Milrinone—Liver function test abnormal—Paclitaxel—breast cancer	0.00302	0.00437	CcSEcCtD
Milrinone—Arrhythmia—Vinorelbine—breast cancer	0.00301	0.00435	CcSEcCtD
Milrinone—Hypokalaemia—Paclitaxel—breast cancer	0.00298	0.00431	CcSEcCtD
Milrinone—Chest pain—Tamoxifen—breast cancer	0.00292	0.00422	CcSEcCtD
Milrinone—Rash—Exemestane—breast cancer	0.0029	0.0042	CcSEcCtD
Milrinone—Dermatitis—Exemestane—breast cancer	0.0029	0.00419	CcSEcCtD
Milrinone—Headache—Exemestane—breast cancer	0.00288	0.00417	CcSEcCtD
Milrinone—Arrhythmia—Thiotepa—breast cancer	0.00287	0.00416	CcSEcCtD
Milrinone—Chest pain—Melphalan—breast cancer	0.00286	0.00413	CcSEcCtD
Milrinone—Ventricular extrasystoles—Epirubicin—breast cancer	0.00285	0.00413	CcSEcCtD
Milrinone—Thrombocytopenia—Vinblastine—breast cancer	0.00282	0.00408	CcSEcCtD
Milrinone—Chest pain—Goserelin—breast cancer	0.00279	0.00403	CcSEcCtD
Milrinone—Anaphylactic shock—Melphalan—breast cancer	0.00274	0.00396	CcSEcCtD
Milrinone—Thrombocytopenia—Tamoxifen—breast cancer	0.00274	0.00396	CcSEcCtD
Milrinone—Rash—Ixabepilone—breast cancer	0.00274	0.00396	CcSEcCtD
Milrinone—Dermatitis—Ixabepilone—breast cancer	0.00273	0.00396	CcSEcCtD
Milrinone—Headache—Ixabepilone—breast cancer	0.00272	0.00393	CcSEcCtD
Milrinone—Thrombocytopenia—Melphalan—breast cancer	0.00268	0.00388	CcSEcCtD
Milrinone—Anaphylactic shock—Goserelin—breast cancer	0.00267	0.00387	CcSEcCtD
Milrinone—Ventricular extrasystoles—Doxorubicin—breast cancer	0.00264	0.00382	CcSEcCtD
Milrinone—Thrombocytopenia—Goserelin—breast cancer	0.00262	0.00378	CcSEcCtD
Milrinone—Ventricular tachycardia—Epirubicin—breast cancer	0.00258	0.00373	CcSEcCtD
Milrinone—Rash—Anastrozole—breast cancer	0.00258	0.00373	CcSEcCtD
Milrinone—Rash—Letrozole—breast cancer	0.00258	0.00373	CcSEcCtD
Milrinone—Dermatitis—Anastrozole—breast cancer	0.00257	0.00373	CcSEcCtD
Milrinone—Dermatitis—Letrozole—breast cancer	0.00257	0.00373	CcSEcCtD
Milrinone—Liver function test abnormal—Docetaxel—breast cancer	0.00256	0.00371	CcSEcCtD
Milrinone—Headache—Letrozole—breast cancer	0.00256	0.0037	CcSEcCtD
Milrinone—Headache—Anastrozole—breast cancer	0.00256	0.0037	CcSEcCtD
Milrinone—Hypotension—Melphalan—breast cancer	0.00256	0.0037	CcSEcCtD
Milrinone—Hypotension—Goserelin—breast cancer	0.0025	0.00361	CcSEcCtD
Milrinone—Chest pain—Vinorelbine—breast cancer	0.0025	0.00361	CcSEcCtD
Milrinone—Arrhythmia—Irinotecan—breast cancer	0.00248	0.00359	CcSEcCtD
Milrinone—Arrhythmia—Mitoxantrone—breast cancer	0.00248	0.00359	CcSEcCtD
Milrinone—Liver function test abnormal—Capecitabine—breast cancer	0.00248	0.00359	CcSEcCtD
Milrinone—Rash—Idarubicin—breast cancer	0.00245	0.00354	CcSEcCtD
Milrinone—Rash—Raloxifene—breast cancer	0.00245	0.00354	CcSEcCtD
Milrinone—Hypokalaemia—Capecitabine—breast cancer	0.00245	0.00354	CcSEcCtD
Milrinone—Dermatitis—Raloxifene—breast cancer	0.00244	0.00354	CcSEcCtD
Milrinone—Dermatitis—Idarubicin—breast cancer	0.00244	0.00354	CcSEcCtD
Milrinone—Headache—Raloxifene—breast cancer	0.00243	0.00352	CcSEcCtD
Milrinone—Headache—Idarubicin—breast cancer	0.00243	0.00352	CcSEcCtD
Milrinone—Arrhythmia—Gemcitabine—breast cancer	0.00242	0.0035	CcSEcCtD
Milrinone—Anaphylactic shock—Vinorelbine—breast cancer	0.00239	0.00346	CcSEcCtD
Milrinone—Ventricular tachycardia—Doxorubicin—breast cancer	0.00239	0.00345	CcSEcCtD
Milrinone—Arrhythmia—Fluorouracil—breast cancer	0.00238	0.00344	CcSEcCtD
Milrinone—Bronchospasm—Docetaxel—breast cancer	0.00236	0.00341	CcSEcCtD
Milrinone—Thrombocytopenia—Vinorelbine—breast cancer	0.00234	0.00339	CcSEcCtD
Milrinone—Angina pectoris—Docetaxel—breast cancer	0.00234	0.00338	CcSEcCtD
Milrinone—Bronchospasm—Capecitabine—breast cancer	0.00228	0.00331	CcSEcCtD
Milrinone—Angina pectoris—Capecitabine—breast cancer	0.00226	0.00327	CcSEcCtD
Milrinone—Thrombocytopenia—Thiotepa—breast cancer	0.00224	0.00324	CcSEcCtD
Milrinone—Hypotension—Vinorelbine—breast cancer	0.00224	0.00323	CcSEcCtD
Milrinone—Chest pain—Mitoxantrone—breast cancer	0.00206	0.00298	CcSEcCtD
Milrinone—Arrhythmia—Paclitaxel—breast cancer	0.00202	0.00293	CcSEcCtD
Milrinone—Chest pain—Gemcitabine—breast cancer	0.00201	0.0029	CcSEcCtD
Milrinone—Anaphylactic shock—Mitoxantrone—breast cancer	0.00197	0.00285	CcSEcCtD
Milrinone—Anaphylactic shock—Irinotecan—breast cancer	0.00197	0.00285	CcSEcCtD
Milrinone—Chest pain—Fluorouracil—breast cancer	0.00197	0.00285	CcSEcCtD
Milrinone—Thrombocytopenia—Mitoxantrone—breast cancer	0.00193	0.0028	CcSEcCtD
Milrinone—Thrombocytopenia—Irinotecan—breast cancer	0.00193	0.0028	CcSEcCtD
Milrinone—Anaphylactic shock—Gemcitabine—breast cancer	0.00192	0.00278	CcSEcCtD
Milrinone—Anaphylactic shock—Fluorouracil—breast cancer	0.00189	0.00273	CcSEcCtD
Milrinone—Thrombocytopenia—Gemcitabine—breast cancer	0.00188	0.00272	CcSEcCtD
Milrinone—Thrombocytopenia—Fluorouracil—breast cancer	0.00185	0.00268	CcSEcCtD
Milrinone—Tremor—Paclitaxel—breast cancer	0.00185	0.00267	CcSEcCtD
Milrinone—Liver function test abnormal—Methotrexate—breast cancer	0.00185	0.00267	CcSEcCtD
Milrinone—Hypotension—Mitoxantrone—breast cancer	0.00184	0.00267	CcSEcCtD
Milrinone—Hypotension—Irinotecan—breast cancer	0.00184	0.00267	CcSEcCtD
Milrinone—Headache—Vinblastine—breast cancer	0.0018	0.00261	CcSEcCtD
Milrinone—Hypotension—Gemcitabine—breast cancer	0.0018	0.0026	CcSEcCtD
Milrinone—Hypotension—Fluorouracil—breast cancer	0.00177	0.00256	CcSEcCtD
Milrinone—Rash—Tamoxifen—breast cancer	0.00176	0.00255	CcSEcCtD
Milrinone—Dermatitis—Tamoxifen—breast cancer	0.00176	0.00255	CcSEcCtD
Milrinone—Headache—Tamoxifen—breast cancer	0.00175	0.00254	CcSEcCtD
Milrinone—Liver function test abnormal—Epirubicin—breast cancer	0.00173	0.0025	CcSEcCtD
Milrinone—Rash—Melphalan—breast cancer	0.00173	0.0025	CcSEcCtD
Milrinone—Dermatitis—Melphalan—breast cancer	0.00173	0.0025	CcSEcCtD
Milrinone—Arrhythmia—Docetaxel—breast cancer	0.00172	0.00248	CcSEcCtD
Milrinone—Hypokalaemia—Epirubicin—breast cancer	0.0017	0.00246	CcSEcCtD
Milrinone—Rash—Goserelin—breast cancer	0.00168	0.00244	CcSEcCtD
Milrinone—Dermatitis—Goserelin—breast cancer	0.00168	0.00243	CcSEcCtD
Milrinone—Chest pain—Paclitaxel—breast cancer	0.00168	0.00243	CcSEcCtD
Milrinone—Headache—Goserelin—breast cancer	0.00167	0.00242	CcSEcCtD
Milrinone—Arrhythmia—Capecitabine—breast cancer	0.00166	0.0024	CcSEcCtD
Milrinone—Anaphylactic shock—Paclitaxel—breast cancer	0.00161	0.00233	CcSEcCtD
Milrinone—Liver function test abnormal—Doxorubicin—breast cancer	0.0016	0.00231	CcSEcCtD
Milrinone—Hypokalaemia—Doxorubicin—breast cancer	0.00158	0.00228	CcSEcCtD
Milrinone—Angina pectoris—Epirubicin—breast cancer	0.00158	0.00228	CcSEcCtD
Milrinone—Thrombocytopenia—Paclitaxel—breast cancer	0.00158	0.00228	CcSEcCtD
Milrinone—Tremor—Capecitabine—breast cancer	0.00152	0.00219	CcSEcCtD
Milrinone—Rash—Vinorelbine—breast cancer	0.00151	0.00218	CcSEcCtD
Milrinone—Dermatitis—Vinorelbine—breast cancer	0.00151	0.00218	CcSEcCtD
Milrinone—Hypotension—Paclitaxel—breast cancer	0.0015	0.00218	CcSEcCtD
Milrinone—Headache—Vinorelbine—breast cancer	0.0015	0.00217	CcSEcCtD
Milrinone—Angina pectoris—Doxorubicin—breast cancer	0.00146	0.00211	CcSEcCtD
Milrinone—Rash—Thiotepa—breast cancer	0.00144	0.00208	CcSEcCtD
Milrinone—Dermatitis—Thiotepa—breast cancer	0.00144	0.00208	CcSEcCtD
Milrinone—Headache—Thiotepa—breast cancer	0.00143	0.00207	CcSEcCtD
Milrinone—Chest pain—Docetaxel—breast cancer	0.00142	0.00206	CcSEcCtD
Milrinone—Chest pain—Capecitabine—breast cancer	0.00138	0.00199	CcSEcCtD
Milrinone—Anaphylactic shock—Docetaxel—breast cancer	0.00136	0.00197	CcSEcCtD
Milrinone—Thrombocytopenia—Docetaxel—breast cancer	0.00134	0.00193	CcSEcCtD
Milrinone—Thrombocytopenia—Capecitabine—breast cancer	0.00129	0.00187	CcSEcCtD
Milrinone—Hypotension—Docetaxel—breast cancer	0.00127	0.00184	CcSEcCtD
Milrinone—PDE3A—Signaling by GPCR—GPER1—breast cancer	0.00125	0.00435	CbGpPWpGaD
Milrinone—Rash—Mitoxantrone—breast cancer	0.00124	0.0018	CcSEcCtD
Milrinone—Rash—Irinotecan—breast cancer	0.00124	0.0018	CcSEcCtD
Milrinone—Dermatitis—Irinotecan—breast cancer	0.00124	0.0018	CcSEcCtD
Milrinone—Dermatitis—Mitoxantrone—breast cancer	0.00124	0.0018	CcSEcCtD
Milrinone—Headache—Irinotecan—breast cancer	0.00124	0.00179	CcSEcCtD
Milrinone—Headache—Mitoxantrone—breast cancer	0.00124	0.00179	CcSEcCtD
Milrinone—Hypotension—Capecitabine—breast cancer	0.00123	0.00179	CcSEcCtD
Milrinone—PDE3A—GPCR downstream signaling—PTGER1—breast cancer	0.00123	0.00427	CbGpPWpGaD
Milrinone—Rash—Gemcitabine—breast cancer	0.00121	0.00175	CcSEcCtD
Milrinone—Dermatitis—Gemcitabine—breast cancer	0.00121	0.00175	CcSEcCtD
Milrinone—Headache—Gemcitabine—breast cancer	0.0012	0.00174	CcSEcCtD
Milrinone—PDE3A—Signaling by GPCR—NMBR—breast cancer	0.0012	0.00418	CbGpPWpGaD
Milrinone—Rash—Fluorouracil—breast cancer	0.00119	0.00172	CcSEcCtD
Milrinone—Dermatitis—Fluorouracil—breast cancer	0.00119	0.00172	CcSEcCtD
Milrinone—Headache—Fluorouracil—breast cancer	0.00118	0.00171	CcSEcCtD
Milrinone—PDE3A—Hemostasis—CFL1—breast cancer	0.00116	0.00402	CbGpPWpGaD
Milrinone—Arrhythmia—Epirubicin—breast cancer	0.00116	0.00167	CcSEcCtD
Milrinone—PDE3A—Hemostasis—GRB7—breast cancer	0.00115	0.00399	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PTGER1—breast cancer	0.00112	0.00388	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CCL27—breast cancer	0.0011	0.00381	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCL3—breast cancer	0.0011	0.00381	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PDE2A—breast cancer	0.0011	0.00381	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ALDOA—breast cancer	0.00108	0.00376	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—VEGFC—breast cancer	0.00108	0.00376	CbGpPWpGaD
Milrinone—Arrhythmia—Doxorubicin—breast cancer	0.00107	0.00155	CcSEcCtD
Milrinone—Chest pain—Methotrexate—breast cancer	0.00103	0.00148	CcSEcCtD
Milrinone—PDE3A—Signaling by GPCR—WNT10B—breast cancer	0.00102	0.00355	CbGpPWpGaD
Milrinone—Rash—Paclitaxel—breast cancer	0.00101	0.00147	CcSEcCtD
Milrinone—Dermatitis—Paclitaxel—breast cancer	0.00101	0.00147	CcSEcCtD
Milrinone—Headache—Paclitaxel—breast cancer	0.00101	0.00146	CcSEcCtD
Milrinone—PDE3A—Signaling by GPCR—CCL27—breast cancer	0.000997	0.00346	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PDE2A—breast cancer	0.000997	0.00346	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCL3—breast cancer	0.000997	0.00346	CbGpPWpGaD
Milrinone—Anaphylactic shock—Methotrexate—breast cancer	0.000983	0.00142	CcSEcCtD
Milrinone—Thrombocytopenia—Methotrexate—breast cancer	0.000963	0.00139	CcSEcCtD
Milrinone—Chest pain—Epirubicin—breast cancer	0.00096	0.00139	CcSEcCtD
Milrinone—Anaphylactic shock—Epirubicin—breast cancer	0.00092	0.00133	CcSEcCtD
Milrinone—Hypotension—Methotrexate—breast cancer	0.000919	0.00133	CcSEcCtD
Milrinone—PDE3A—Hemostasis—TGFB2—breast cancer	0.000913	0.00317	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—THBS1—breast cancer	0.000908	0.00315	CbGpPWpGaD
Milrinone—Thrombocytopenia—Epirubicin—breast cancer	0.000901	0.0013	CcSEcCtD
Milrinone—PDE3A—Hemostasis—GATA3—breast cancer	0.000895	0.00311	CbGpPWpGaD
Milrinone—Chest pain—Doxorubicin—breast cancer	0.000888	0.00128	CcSEcCtD
Milrinone—Rash—Docetaxel—breast cancer	0.00086	0.00124	CcSEcCtD
Milrinone—Hypotension—Epirubicin—breast cancer	0.00086	0.00124	CcSEcCtD
Milrinone—Dermatitis—Docetaxel—breast cancer	0.000859	0.00124	CcSEcCtD
Milrinone—Headache—Docetaxel—breast cancer	0.000854	0.00124	CcSEcCtD
Milrinone—Anaphylactic shock—Doxorubicin—breast cancer	0.000851	0.00123	CcSEcCtD
Milrinone—Thrombocytopenia—Doxorubicin—breast cancer	0.000833	0.00121	CcSEcCtD
Milrinone—Rash—Capecitabine—breast cancer	0.000833	0.0012	CcSEcCtD
Milrinone—Dermatitis—Capecitabine—breast cancer	0.000832	0.0012	CcSEcCtD
Milrinone—Headache—Capecitabine—breast cancer	0.000827	0.0012	CcSEcCtD
Milrinone—PDE3A—Hemostasis—IFNB1—breast cancer	0.000803	0.00279	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—RGS2—breast cancer	0.000803	0.00279	CbGpPWpGaD
Milrinone—Hypotension—Doxorubicin—breast cancer	0.000795	0.00115	CcSEcCtD
Milrinone—PDE3A—GPCR downstream signaling—CCL20—breast cancer	0.000794	0.00275	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LGR6—breast cancer	0.000777	0.0027	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCDC88C—breast cancer	0.000777	0.0027	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—LPAR1—breast cancer	0.000769	0.00267	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SFRP1—breast cancer	0.000741	0.00257	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GPER1—breast cancer	0.000741	0.00257	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PLAUR—breast cancer	0.000738	0.00256	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—RGS2—breast cancer	0.000729	0.00253	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PDE4D—breast cancer	0.000726	0.00252	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PLG—breast cancer	0.000721	0.0025	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CCL20—breast cancer	0.000721	0.0025	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NMBR—breast cancer	0.000711	0.00247	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CNR2—breast cancer	0.000707	0.00245	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—LPAR1—breast cancer	0.000698	0.00242	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PDGFA—breast cancer	0.000685	0.00238	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ITPR1—breast cancer	0.000664	0.0023	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CUL5—breast cancer	0.000661	0.00229	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HEYL—breast cancer	0.000661	0.00229	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTGER1—breast cancer	0.000661	0.00229	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ABL1—breast cancer	0.00066	0.00229	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PDE4D—breast cancer	0.000659	0.00229	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CNR2—breast cancer	0.000642	0.00223	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RSPO3—breast cancer	0.000621	0.00216	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—HGF—breast cancer	0.00062	0.00215	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PLA2G4A—breast cancer	0.00062	0.00215	CbGpPWpGaD
Milrinone—Rash—Methotrexate—breast cancer	0.00062	0.000897	CcSEcCtD
Milrinone—Dermatitis—Methotrexate—breast cancer	0.000619	0.000896	CcSEcCtD
Milrinone—Headache—Methotrexate—breast cancer	0.000616	0.000891	CcSEcCtD
Milrinone—PDE3A—Hemostasis—CSF2—breast cancer	0.000613	0.00213	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—AGTR2—breast cancer	0.000608	0.00211	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCL2—breast cancer	0.000608	0.00211	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—WWOX—breast cancer	0.000604	0.0021	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—WNT10B—breast cancer	0.000604	0.0021	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—WNT1—breast cancer	0.000604	0.0021	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PTHLH—breast cancer	0.000602	0.00209	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—INHBB—breast cancer	0.000589	0.00204	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDE2A—breast cancer	0.000589	0.00204	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCL27—breast cancer	0.000589	0.00204	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCL3—breast cancer	0.000589	0.00204	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—EDNRB—breast cancer	0.000583	0.00202	CbGpPWpGaD
Milrinone—Rash—Epirubicin—breast cancer	0.00058	0.000839	CcSEcCtD
Milrinone—Dermatitis—Epirubicin—breast cancer	0.00058	0.000839	CcSEcCtD
Milrinone—Headache—Epirubicin—breast cancer	0.000576	0.000834	CcSEcCtD
Milrinone—PDE3A—Signaling Pathways—DLL4—breast cancer	0.000562	0.00195	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BMPR2—breast cancer	0.000562	0.00195	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCL2—breast cancer	0.000552	0.00192	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—AGTR2—breast cancer	0.000552	0.00192	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PTHLH—breast cancer	0.000546	0.0019	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDH5—breast cancer	0.000539	0.00187	CbGpPWpGaD
Milrinone—Rash—Doxorubicin—breast cancer	0.000537	0.000777	CcSEcCtD
Milrinone—Dermatitis—Doxorubicin—breast cancer	0.000536	0.000776	CcSEcCtD
Milrinone—Headache—Doxorubicin—breast cancer	0.000533	0.000772	CcSEcCtD
Milrinone—PDE3A—GPCR downstream signaling—CALCA—breast cancer	0.00053	0.00184	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—EDNRB—breast cancer	0.000529	0.00184	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SFRP2—breast cancer	0.000528	0.00183	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—MMP1—breast cancer	0.000527	0.00183	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PRLR—breast cancer	0.000518	0.0018	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CDK2—breast cancer	0.000518	0.0018	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PLAU—breast cancer	0.000518	0.0018	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCR4—breast cancer	0.000517	0.00179	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCL12—breast cancer	0.000517	0.00179	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CAV1—breast cancer	0.000506	0.00175	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—VCP—breast cancer	0.000501	0.00174	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GLI2—breast cancer	0.000501	0.00174	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LEPR—breast cancer	0.000493	0.00171	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—FN1—breast cancer	0.000481	0.00167	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CALCA—breast cancer	0.000481	0.00167	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—NOS2—breast cancer	0.000476	0.00165	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCL12—breast cancer	0.00047	0.00163	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCR4—breast cancer	0.00047	0.00163	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—AGTR1—breast cancer	0.000468	0.00162	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CG—breast cancer	0.000461	0.0016	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ARHGDIA—breast cancer	0.000458	0.00159	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—EGF—breast cancer	0.000455	0.00158	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FST—breast cancer	0.000446	0.00155	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HEY2—breast cancer	0.000441	0.00153	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RPS6KB2—breast cancer	0.000436	0.00151	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RGS2—breast cancer	0.000431	0.00149	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCL20—breast cancer	0.000426	0.00148	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—AGTR1—breast cancer	0.000425	0.00147	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IGF1—breast cancer	0.000422	0.00146	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—AKT2—breast cancer	0.000421	0.00146	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—ITPR1—breast cancer	0.00042	0.00146	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TLE3—breast cancer	0.000412	0.00143	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LPAR1—breast cancer	0.000412	0.00143	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HEY1—breast cancer	0.000408	0.00142	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CD—breast cancer	0.000405	0.00141	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—SERPINE1—breast cancer	0.0004	0.00139	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—DLL1—breast cancer	0.0004	0.00139	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ALB—breast cancer	0.0004	0.00139	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HIST1H2BC—breast cancer	0.000393	0.00136	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HIST1H2BK—breast cancer	0.000393	0.00136	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GRB7—breast cancer	0.000389	0.00135	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDE4D—breast cancer	0.000389	0.00135	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CSF2—breast cancer	0.000388	0.00135	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TAB2—breast cancer	0.000383	0.00133	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—NOS3—breast cancer	0.000382	0.00133	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—ITPR1—breast cancer	0.000381	0.00132	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CNR2—breast cancer	0.00038	0.00132	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—MMP3—breast cancer	0.000379	0.00131	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—DKK1—breast cancer	0.00037	0.00129	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—VEGFC—breast cancer	0.000368	0.00128	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JAG2—breast cancer	0.000362	0.00126	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—RAF1—breast cancer	0.000361	0.00125	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—WNT1—breast cancer	0.000357	0.00124	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PLA2G4A—breast cancer	0.000356	0.00124	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CB—breast cancer	0.000353	0.00122	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CSF2—breast cancer	0.000352	0.00122	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NOTCH4—breast cancer	0.000338	0.00117	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GZMB—breast cancer	0.000336	0.00117	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AGTR2—breast cancer	0.000326	0.00113	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCL2—breast cancer	0.000326	0.00113	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IL2—breast cancer	0.000324	0.00112	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTHLH—breast cancer	0.000323	0.00112	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BMP2—breast cancer	0.000323	0.00112	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EDNRB—breast cancer	0.000313	0.00108	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PGR—breast cancer	0.000309	0.00107	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—THBS1—breast cancer	0.000308	0.00107	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FLT1—breast cancer	0.000294	0.00102	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SQSTM1—breast cancer	0.000293	0.00102	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF3—breast cancer	0.000293	0.00102	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CG—breast cancer	0.000291	0.00101	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JAG1—breast cancer	0.000289	0.001	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PARP1—breast cancer	0.000288	0.000998	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NOTCH3—breast cancer	0.000288	0.000998	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CALCA—breast cancer	0.000284	0.000986	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—SRC—breast cancer	0.000283	0.000981	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RPS6—breast cancer	0.000281	0.000974	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF4—breast cancer	0.000279	0.000967	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCR4—breast cancer	0.000277	0.000963	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCL12—breast cancer	0.000277	0.000963	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—VEGFA—breast cancer	0.000275	0.000956	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PAK1—breast cancer	0.000272	0.000945	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TCF7L2—breast cancer	0.000268	0.000929	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—AKT2—breast cancer	0.000266	0.000924	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CG—breast cancer	0.000264	0.000917	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—MAPK3—breast cancer	0.000261	0.000904	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HSP90AA1—breast cancer	0.000258	0.000895	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NOTCH2—breast cancer	0.000258	0.000895	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CD—breast cancer	0.000256	0.000888	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—TGFB1—breast cancer	0.000253	0.000877	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PRL—breast cancer	0.000251	0.000871	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AGTR1—breast cancer	0.000251	0.000871	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ADAM10—breast cancer	0.000247	0.000858	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STK11—breast cancer	0.000247	0.000858	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PLG—breast cancer	0.000245	0.000849	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—AKT2—breast cancer	0.000242	0.000839	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF10—breast cancer	0.000241	0.000835	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—KRAS—breast cancer	0.000234	0.000813	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CD—breast cancer	0.000232	0.000806	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDGFA—breast cancer	0.000232	0.000806	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TGFBR2—breast cancer	0.000229	0.000794	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ITPR1—breast cancer	0.000225	0.000781	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ERBB4—breast cancer	0.000224	0.000776	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MMP3—breast cancer	0.000224	0.000776	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STAT5A—breast cancer	0.000224	0.000776	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CB—breast cancer	0.000223	0.000774	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SMAD4—breast cancer	0.000217	0.000752	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IGF1R—breast cancer	0.000215	0.000747	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CA—breast cancer	0.000215	0.000747	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCL8—breast cancer	0.000214	0.000744	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HES1—breast cancer	0.000212	0.000734	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PLA2G4A—breast cancer	0.00021	0.00073	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NCOR1—breast cancer	0.00021	0.00073	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—TP53—breast cancer	0.000208	0.000722	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF1—breast cancer	0.000208	0.000722	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CSF2—breast cancer	0.000208	0.000722	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—RAF1—breast cancer	0.000207	0.00072	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NRG1—breast cancer	0.000206	0.000716	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—H2AFX—breast cancer	0.000205	0.000711	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—IL2—breast cancer	0.000205	0.000711	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—E2F1—breast cancer	0.000203	0.000706	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CB—breast cancer	0.000203	0.000703	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—HRAS—breast cancer	0.000199	0.000691	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SPP1—breast cancer	0.000196	0.000678	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCL8—breast cancer	0.000195	0.000675	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ERBB3—breast cancer	0.000193	0.000671	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGFR2—breast cancer	0.000193	0.00067	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL2—breast cancer	0.000186	0.000645	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TERT—breast cancer	0.000185	0.000643	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGFR1—breast cancer	0.00018	0.000624	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HIF1A—breast cancer	0.000177	0.000615	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—AKT1—breast cancer	0.000176	0.00061	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LEP—breast cancer	0.000173	0.0006	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CAV1—breast cancer	0.000171	0.000595	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KDR—breast cancer	0.00017	0.000588	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ESR1—breast cancer	0.000165	0.000573	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FN1—breast cancer	0.000163	0.000566	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NFKBIA—breast cancer	0.000161	0.00056	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NOTCH1—breast cancer	0.00016	0.000554	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KIT—breast cancer	0.000156	0.000542	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—APC—breast cancer	0.000156	0.000542	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CG—breast cancer	0.000156	0.000542	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EGF—breast cancer	0.000154	0.000536	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—MAPK3—breast cancer	0.00015	0.000519	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BRAF—breast cancer	0.000147	0.000509	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IGF1—breast cancer	0.000143	0.000496	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AKT2—breast cancer	0.000143	0.000496	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—EGFR—breast cancer	0.000142	0.000494	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CD—breast cancer	0.000137	0.000476	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CA—breast cancer	0.000136	0.000472	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SERPINE1—breast cancer	0.000136	0.000471	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—KRAS—breast cancer	0.000134	0.000466	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NOS3—breast cancer	0.00013	0.00045	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CA—breast cancer	0.000123	0.000428	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MDM2—breast cancer	0.000123	0.000427	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RAF1—breast cancer	0.000123	0.000425	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RELA—breast cancer	0.000122	0.000423	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ERBB2—breast cancer	0.000121	0.000421	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CB—breast cancer	0.00012	0.000415	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MTOR—breast cancer	0.00012	0.000415	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCL8—breast cancer	0.000115	0.000399	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—HRAS—breast cancer	0.000114	0.000396	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDKN1B—breast cancer	0.000112	0.00039	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—AKT1—breast cancer	0.000111	0.000385	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CASP3—breast cancer	0.00011	0.000382	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL2—breast cancer	0.00011	0.000381	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL6—breast cancer	0.000109	0.000379	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCND1—breast cancer	0.000107	0.000372	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JUN—breast cancer	0.000107	0.000371	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CTNNB1—breast cancer	0.000106	0.000368	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MMP9—breast cancer	0.000104	0.000361	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDKN1A—breast cancer	0.000104	0.00036	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTEN—breast cancer	0.000103	0.000359	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAPK8—breast cancer	0.000101	0.000351	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—AKT1—breast cancer	0.000101	0.00035	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SRC—breast cancer	9.59e-05	0.000333	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—VEGFA—breast cancer	9.34e-05	0.000324	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STAT3—breast cancer	9.25e-05	0.000321	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAPK3—breast cancer	8.83e-05	0.000307	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MYC—breast cancer	8.59e-05	0.000298	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TGFB1—breast cancer	8.57e-05	0.000297	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EGFR—breast cancer	8.4e-05	0.000292	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KRAS—breast cancer	7.94e-05	0.000276	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CA—breast cancer	7.29e-05	0.000253	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TP53—breast cancer	7.06e-05	0.000245	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HRAS—breast cancer	6.75e-05	0.000234	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL6—breast cancer	6.46e-05	0.000224	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AKT1—breast cancer	5.96e-05	0.000207	CbGpPWpGaD
